Supriya Lifesci.

38
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
620.25
-4.2 (-0.67%)
BSENSE

Nov 20

BSE+NSE Vol: 1.47 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 18.86% vs 22.12% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 12.75% vs 50.77% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 12.04% vs -20.09% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 11.26% vs 57.80% in Mar 2025

Compare Profit and Loss Results of Supriya Lifesci.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
914.00
106.00
808.00
762.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
86.00
0.00
86.00
0%
Net Sales
827.00
106.00
721.00
680.19%
Expenditure (Ex Depriciation)
Stock Adjustments
-11.00
0.00
-11.00
0%
Raw Materials Consumed
265.00
54.00
211.00
390.74%
Power & Fuel Cost
29.00
2.00
27.00
1,350.00%
Employee Cost
96.00
38.00
58.00
152.63%
Operating Expenses
80.00
13.00
67.00
515.38%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
32.00
0.00
32.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
0.00
14.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
533.00
124.00
409.00
329.84%
Operating Profit (PBDIT) excl Other Income
294.00
-18.00
312.00
1,733.33%
Other Income
11.00
66.00
-55.00
-83.33%
Operating Profit (PBDIT)
305.00
47.00
258.00
548.94%
Interest
1.00
6.00
-5.00
-83.33%
Profit before Depriciation and Tax
303.00
40.00
263.00
657.50%
Depreciation
28.00
13.00
15.00
115.38%
Profit Before Taxation & Exceptional Items
275.00
27.00
248.00
918.52%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
274.00
27.00
247.00
914.81%
Provision for Tax
65.00
7.00
58.00
828.57%
Profit After Tax
209.00
20.00
189.00
945.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
781.00
7.00
774.00
11,057.14%
Profit Available for appropriations
991.00
27.00
964.00
3,570.37%
Appropriations
991.00
27.00
964.00
3,570.37%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
25.98
4.4
21.58
490.45%
Profit And Loss - Net Sales
Net Sales 827.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 18.86% vs 22.12% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 294.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.75% vs 50.77% in Mar 2025

Profit And Loss - Interest
Interest 1.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.04% vs -20.09% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 209.12 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.26% vs 57.80% in Mar 2025